Innovex International (INVX) Cash & Equivalents (2009 - 2026)

Innovex International has reported Cash & Equivalents for 18 years, with the latest figure at $200.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 194.65% year-over-year to $200.7 million; the trailing twelve-month figure through Mar 2026 stood at $200.7 million (up 194.65% YoY), and the FY2025 full-year result was $203.4 million, up 177.58% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $200.7 million, down from $203.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $338.0 million in Q1 2022, with the low at $7.4 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $137.7 million across 5 years, with a median of $99.9 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 97.14% — and 2024, when it surged 1102.54%.
• Innovex International's Cash & Equivalents stood at $8.4 million in 2022, then slipped by 12.0% to $7.4 million in 2023, then surged by 889.44% to $73.3 million in 2024, then soared by 177.58% to $203.4 million in 2025, then dropped by 1.33% to $200.7 million in 2026.
• The last three Cash & Equivalents figures came in at $200.7 million (Q1 2026), $203.4 million (Q4 2025), and $163.4 million (Q3 2025), per Business Quant data.